We apologize for the inconvenience

The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

You will be automatically re-directed to People Search on yellowpages.com in .

Please note our privacy policy has changed. To view the policy, please go to https://corporate.thryv.com/privacy/

Details

General Info

Alicia Lieberman, MD, is a board-certified adult and pediatric rheumatologist in Batavia, New York. Dr. Lieberman provides evidence-based, holistic solutions and individualized care for autoimmune and inflammatory disorders.She attended Cornell University for her undergraduate studies before pursuing her masters degree in natural sciences (with a focus on immunology) at the University at Buffalo. After graduating, she then went on to complete her medical education at SUNY at Buffalo.Following medical school, Dr. Lieberman completed a residency training program in pediatrics and internal medicine at the University of Rochester Medical Center (URMC). She decided to stay with the medical center for her dual fellowship in pediatric and adult rheumatology. With a passion for rheumatologic care, Dr. Lieberman has contributed to several academic publications.Dr. Lieberman specializes in both pediatric and adult rheumatology. For every patient, she provides ample time to discuss their concerns and treatment goals, listening intently to ensure they receive the proper care for their conditions.For a patient-centered approach to autoimmune and inflammatory conditions, call the office of Alicia Liberman, MD, or book an appointment online today.

HoursOPEN NOW
Regular Hours:
Mon - Fri

Contact Info

Phone:

Main - 585-304-8118

Fax - 833-464-3001

Address:
5762 E Main Street Rd Batavia, NY 14020

Reviews

Be the first to review!
Write a Review
Category
Physicians & Surgeons
Suggest an Edit
Are you the business owner?Claim This Business
Data provided by one or more of the following: Thryv, Data Axle, Yext.